Published in Diabet Med on July 01, 2006
Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia (2009) 2.34
Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care (2013) 1.79
Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care (2011) 1.77
Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes. J Diabetes Sci Technol (2007) 1.66
Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open (2013) 1.45
Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial. Can Fam Physician (2008) 1.18
Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence. Clin Med Res (2008) 1.17
Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia. J Diabetes Sci Technol (2009) 1.14
Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol Ther (2013) 0.99
Common standards of basal insulin titration in type 2 diabetes. J Diabetes Sci Technol (2013) 0.99
Glycemic control in community-dwelling patients with type 2 diabetes. Can Pharm J (Ott) (2012) 0.97
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Diabetes Obes Metab (2011) 0.97
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom. Cardiovasc Diabetol (2008) 0.88
Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Exp Diabetes Res (2010) 0.87
Common crossroads in diabetes management. Osteopath Med Prim Care (2008) 0.86
Initiating insulin in patients with type 2 diabetes. CMAJ (2012) 0.86
Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial. BMC Health Serv Res (2013) 0.85
How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment. Diabetes Care (2013) 0.84
Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir. Diabetes Technol Ther (2010) 0.84
Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use). Adv Ther (2013) 0.82
Combining basal insulin analogs with glucagon-like peptide-1 mimetics. Diabetes Technol Ther (2011) 0.81
Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis. Diabet Med (2012) 0.81
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4. Diabetes Obes Metab (2016) 0.81
Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes Metab Res Rev (2012) 0.80
Insulin initiation and intensification in patients with T2DM for the primary care physician. Diabetes Metab Syndr Obes (2011) 0.80
Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value. Core Evid (2007) 0.80
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy. Int J Clin Pract (2012) 0.80
Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus. J Diabetes Sci Technol (2015) 0.78
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials. BMC Endocr Disord (2016) 0.77
Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial. Diabetes Obes Metab (2013) 0.76
[The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus]. Wien Klin Wochenschr (2009) 0.76
BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin. BMJ Open Diabetes Res Care (2016) 0.75
Strategies for initiating insulin in type 2 diabetes. Can Fam Physician (2011) 0.75
Breaking down barriers to initiating insulin: Insulin prescription pad. Can Fam Physician (2015) 0.75
Clinical considerations for insulin pharmacotherapy in ambulatory care, part two: review of primary literature and an evidence-based approach for treatment. Clin Diabetes (2015) 0.75
How much is too much? Outcomes in patients using high-dose insulin glargine. Int J Clin Pract (2015) 0.75
Economic analysis of insulin initiation by pharmacists in a Canadian setting: The RxING study. Can Pharm J (Ott) (2016) 0.75
Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations. Diabetes Ther (2017) 0.75
Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully. Int J Clin Pract (2017) 0.75
Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study. Diabetes Ther (2017) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
The Effect of Abnormal Chromosome 10 on Preferential Segregation and Crossing over in Maize. Genetics (1966) 3.04
Chromosome elimination in maize induced by supernumerary B chromosomes. Proc Natl Acad Sci U S A (1967) 2.93
Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord (2004) 2.54
The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43
On the mechanism of chromatin loss induced by the B chromosome of maize. Genetics (1972) 2.38
Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28
Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q (1996) 2.16
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06
Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04
Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03
Induction of chromosome doubling at meiosis by the elongate gene in maize. Genetics (1966) 1.92
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Overweight among children and adolescents in a Native Canadian community: prevalence and associated factors. Am J Clin Nutr (2000) 1.76
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70
How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
The rupture rate of acute flexor tendon repairs mobilized by the controlled active motion regimen. J Hand Surg Br (1994) 1.60
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60
Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57
Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care (1997) 1.55
Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr (1998) 1.53
The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab (1999) 1.50
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50
Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49
The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48
Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Natl Acad Sci U S A (1992) 1.45
Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (Lond) (2007) 1.43
Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42
Mammography after treatment for breast cancer. BMJ (1994) 1.40
Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39
Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39
Process evaluation of a multi-institutional community-based program for diabetes prevention among First Nations. Health Educ Res (2007) 1.39
Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38
Edge strength of resin-composite margins. Dent Mater (2007) 1.36
Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32
Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31
Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther (2004) 1.31
Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29
Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol (2000) 1.27
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26
Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab (1999) 1.26
Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Maternal nutritional status, diabetes and risk of macrosomia among Native Canadian women. Early Hum Dev (1998) 1.23
Body image concepts differ by age and sex in an Ojibway-Cree community in Canada. J Nutr (1996) 1.22
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20
Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care (2001) 1.20
Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18
Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin Infect Dis (1995) 1.18
Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17
The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arterioscler Thromb Vasc Biol (2000) 1.16
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med (1983) 1.16
Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers. J Hum Genet (1999) 1.14
Retracted Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet (1995) 1.11
Vitrification enhancement by synthetic ice blocking agents. Cryobiology (2000) 1.10
Herpesvirus simiae contamination of primary rhesus monkey kidney cell cultures. CDC recommendations to minimize risks to laboratory personnel. Diagn Microbiol Infect Dis (1990) 1.10
Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects. Eye (Lond) (2004) 1.08
Dietary restriction and aging: historical phases, mechanisms and current directions. J Nutr (1987) 1.06
Prevalence of anemia in First Nations children of northwestern Ontario. Can Fam Physician (1997) 1.06
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study. Int J Clin Pract (2012) 1.05
Helicobacter pylori cagA status, vacA genotypes and ulcer disease. Eur J Gastroenterol Hepatol (1998) 1.05
Highly potent neurotensin analog that causes hypothermia and antinociception. Eur J Pharmacol (2000) 1.04
Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond) (2006) 1.03
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol (1997) 1.03
Transient monoclonal gammopathy associated with cytomegalovirus infection. Blood (1974) 1.02
Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Summ (1992) 1.02
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol (2004) 1.02
Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord (2003) 1.01
Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications. Circulation (1989) 1.01
Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.00
Development of an integrated diabetes prevention program with First Nations in Canada. Health Promot Int (2006) 1.00
Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab (2000) 1.00
Immune-complex glomerulonephritis associated with cytomegalovirus infection. Am J Clin Pathol (1979) 1.00
Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan. APMIS (2005) 0.99
Hemiparasitic plant impacts animal and plant communities across four trophic levels. Ecology (2015) 0.99
Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol (1996) 0.99
The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol (1998) 0.98
The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure. J Glaucoma (1998) 0.98
Partners for life: the transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematology (2006) 0.98